Literature DB >> 7874125

Diverse mutations of the P gene among African-Americans with type II (tyrosinase-positive) oculocutaneous albinism (OCA2).

S T Lee1, R D Nicholls, R E Schnur, L C Guida, J Lu-Kuo, N B Spinner, E H Zackai, R A Spritz.   

Abstract

Type II (tyrosinase-positive) oculocutaneous albinism (OCA2) is an autosomal recessive disorder in which the biosynthesis of melanin pigment is reduced in the skin, hair, and eyes. OCA2, which we have shown results from mutations of the P gene in Caucasians, is the most prevalent type of oculocutaneous albinism in African and African-American patients with OCA. We have identified abnormalities of the P gene in seven unrelated African-American patients with OCA2, including three large deletions, two small in-frame deletions, and six different point mutations. None of these appears to be predominant among African-American patients with OCA2.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7874125

Source DB:  PubMed          Journal:  Hum Mol Genet        ISSN: 0964-6906            Impact factor:   6.150


  16 in total

Review 1.  Sequences associated with human iris pigmentation.

Authors:  Tony Frudakis; Matthew Thomas; Zach Gaskin; K Venkateswarlu; K Suresh Chandra; Siva Ginjupalli; Sitaram Gunturi; Sivamani Natrajan; Viswanathan K Ponnuswamy; K N Ponnuswamy
Journal:  Genetics       Date:  2003-12       Impact factor: 4.562

2.  Genetic testing for oculocutaneous albinism type 1 and 2 and Hermansky-Pudlak syndrome type 1 and 3 mutations in Puerto Rico.

Authors:  Pedro J Santiago Borrero; Yolanda Rodríguez-Pérez; Jessicca Y Renta; Natalio J Izquierdo; Laura Del Fierro; Daniel Muñoz; Norma López Molina; Sonia Ramírez; Glorivee Pagán-Mercado; Idith Ortíz; Enid Rivera-Caragol; Richard A Spritz; Carmen L Cadilla
Journal:  J Invest Dermatol       Date:  2006-01       Impact factor: 8.551

3.  Clinical utility gene card for: Oculocutaneous albinism.

Authors:  Karen Grønskov; Karen Brøndum-Nielsen; Birgit Lorenz; Markus N Preising
Journal:  Eur J Hum Genet       Date:  2014-02-12       Impact factor: 4.246

4.  Hypopigmentation in the Prader-Willi syndrome correlates with P gene deletion but not with haplotype of the hemizygous P allele.

Authors:  R A Spritz; T Bailin; R D Nicholls; S T Lee; S K Park; M J Mascari; M G Butler
Journal:  Am J Med Genet       Date:  1997-07-11

5.  Congenital cataract and macular hypoplasia in humans associated with a de novo mutation in CRYAA and compound heterozygous mutations in P.

Authors:  Jochen Graw; Norman Klopp; Thomas Illig; Markus N Preising; Birgit Lorenz
Journal:  Graefes Arch Clin Exp Ophthalmol       Date:  2006-02-02       Impact factor: 3.117

6.  Differential gene expression of TRPM1, the potential cause of congenital stationary night blindness and coat spotting patterns (LP) in the Appaloosa horse (Equus caballus).

Authors:  Rebecca R Bellone; Samantha A Brooks; Lynne Sandmeyer; Barbara A Murphy; George Forsyth; Sheila Archer; Ernest Bailey; Bruce Grahn
Journal:  Genetics       Date:  2008-07-27       Impact factor: 4.562

7.  MC1R mutations modify the classic phenotype of oculocutaneous albinism type 2 (OCA2).

Authors:  Richard A King; Rebecca K Willaert; Ramona M Schmidt; Jacy Pietsch; Sarah Savage; Marcia J Brott; James P Fryer; C Gail Summers; William S Oetting
Journal:  Am J Hum Genet       Date:  2003-07-22       Impact factor: 11.025

8.  Frequent intragenic deletion of the P gene in Tanzanian patients with type II oculocutaneous albinism (OCA2).

Authors:  R A Spritz; K Fukai; S A Holmes; J Luande
Journal:  Am J Hum Genet       Date:  1995-06       Impact factor: 11.025

9.  Tyrosinase gene mutations in oculocutaneous albinism 1 (OCA1): definition of the phenotype.

Authors:  Richard A King; Jacy Pietsch; James P Fryer; Sarah Savage; Marcia J Brott; Isabelle Russell-Eggitt; C Gail Summers; William S Oetting
Journal:  Hum Genet       Date:  2003-09-10       Impact factor: 4.132

10.  Gene expression studies in multiple sclerosis.

Authors:  Lotti Tajouri; Francesca Fernandez; Lyn R Griffiths
Journal:  Curr Genomics       Date:  2007-05       Impact factor: 2.236

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.